TG Therapeutics, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by TG Therapeutics, Inc.
RECRUITINGPhase 1NCT06680037
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-cel).
Sponsor: TG Therapeutics, Inc.Enrolling: 328 locations
B-cell Mediated Autoimmune Disorders
RECRUITINGNCT06143514
A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
The primary objective of the lactation study is to characterize the presence and concentration of BRIUMVI™ in breast milk among breastfeeding participants who receive BRIUMVI™...
Sponsor: TG Therapeutics, Inc.Enrolling: 164 locations
Relapsing Multiple Sclerosis